Granulomatous vasculitis after the AstraZeneca anti-SARS-CoV-2 vaccine
Kidney Int
.
2021 Sep;100(3):706-707.
doi: 10.1016/j.kint.2021.06.033.
Epub 2021 Jul 5.
Authors
Valentine Gillion
1
,
Michel Jadoul
1
,
Nathalie Demoulin
1
,
Selda Aydin
2
,
Arnaud Devresse
3
Affiliations
1
Department of Nephrology, Saint Luc University Clinics, Brussels, Belgium.
2
Department of Pathology, Saint Luc University Clinics, Brussels, Belgium.
3
Department of Nephrology, Saint Luc University Clinics, Brussels, Belgium. Electronic address: arnaud.devresse@uclouvain.be.
PMID:
34237323
PMCID:
PMC8256676
DOI:
10.1016/j.kint.2021.06.033
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2
Vasculitis*
Substances
COVID-19 Vaccines